GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » PB Ratio

YIFAN PHARMACEUTICAL CO (SZSE:002019) PB Ratio : 2.02 (As of May. 12, 2024)


View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-12), YIFAN PHARMACEUTICAL CO's share price is ¥13.88. YIFAN PHARMACEUTICAL CO's Book Value per Share for the quarter that ended in Mar. 2024 was ¥6.86. Hence, YIFAN PHARMACEUTICAL CO's PB Ratio of today is 2.02.

The historical rank and industry rank for YIFAN PHARMACEUTICAL CO's PB Ratio or its related term are showing as below:

SZSE:002019' s PB Ratio Range Over the Past 10 Years
Min: 1.44   Med: 3.31   Max: 17.79
Current: 2.02

During the past 13 years, YIFAN PHARMACEUTICAL CO's highest PB Ratio was 17.79. The lowest was 1.44. And the median was 3.31.

SZSE:002019's PB Ratio is ranked worse than
50.21% of 956 companies
in the Drug Manufacturers industry
Industry Median: 2.01 vs SZSE:002019: 2.02

During the past 12 months, YIFAN PHARMACEUTICAL CO's average Book Value Per Share Growth Rate was -5.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -0.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 4.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 20.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of YIFAN PHARMACEUTICAL CO was 66.00% per year. The lowest was -19.20% per year. And the median was 26.00% per year.

Back to Basics: PB Ratio


YIFAN PHARMACEUTICAL CO PB Ratio Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO PB Ratio Chart

YIFAN PHARMACEUTICAL CO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.68 2.77 2.55 1.70 2.19

YIFAN PHARMACEUTICAL CO Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.94 1.99 1.87 2.19 1.62

Competitive Comparison of YIFAN PHARMACEUTICAL CO's PB Ratio

For the Drug Manufacturers - General subindustry, YIFAN PHARMACEUTICAL CO's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YIFAN PHARMACEUTICAL CO's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, YIFAN PHARMACEUTICAL CO's PB Ratio distribution charts can be found below:

* The bar in red indicates where YIFAN PHARMACEUTICAL CO's PB Ratio falls into.



YIFAN PHARMACEUTICAL CO PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

YIFAN PHARMACEUTICAL CO's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=13.88/6.858
=2.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


YIFAN PHARMACEUTICAL CO  (SZSE:002019) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


YIFAN PHARMACEUTICAL CO PB Ratio Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Traded in Other Exchanges
N/A
Address
No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300
YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines